Bank & Trust CO Vincerx Pharma, Inc. Call Options Transaction History
Bank & Trust CO
- $119 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VINC
# of Institutions
21Shares Held
4.8MCall Options Held
0Put Options Held
0-
Sage Rhino Capital LLC1.7MShares$1.11 Million0.1% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$579,6170.01% of portfolio
-
Goldman Sachs Group Inc New York, NY631KShares$410,4080.0% of portfolio
-
Armistice Capital, LLC New York, NY567KShares$368,5570.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA286KShares$186,1410.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $13.8M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...